Clinical Trial Update: A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients [Phase 1, Phase 2]

View source ↗

Summary

A dose-escalation Phase 1/2 trial of tenofovir alafenamide in treatment-naive HIV patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED